Aurobindo Pharma Limited has informed the Exchange regarding Appointment of RPR & Associates as Secretarial Auditor of the company w.e.f. May 21, 2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has informed the exchanges about a change in its secretarial auditor. M/s. MRR & Associates resigned effective May 22, 2026 due to health issues of its sole proprietor. The Board of Directors has appointed M/s. RPR & Associates, a peer-reviewed firm of Company Secretaries, as the new Secretarial Auditor for a term of five consecutive years (FY 2026-27 to FY 2030-31). The appointment is subject to shareholder approval at the ensuing Annual General Meeting. The new auditor, led by Mr. Y. Ravi Prasada Reddy with over 23 years of experience, specializes in Corporate Laws, SEBI Regulations, and FEMA Regulations. The Board meeting was held on May 21, 2026 from 4:30 PM to 6:25 PM.
This is a routine governance update with no direct financial impact. The change of secretarial auditor ensures continued compliance with SEBI listing requirements and statutory obligations.